quantisnow
FeedTopReportsPricing
⌘K
Live feed
08:15:00·16d
PRRelease
BioRestorative Therapies Inc. logo

BioRestorative Therapies Announces Strategic Collaboration with 203 Creates to Build and Commercialize Biocosmeceutical Platform

BRTX· BioRestorative Therapies Inc.
Health Care
Original source

Companies

  • BRTX
    BioRestorative Therapies Inc.
    Health Care

Recent analyst ratings

  • Dec 1UpdateRoth Capital$37.00

Related

  • SEC8h
    BioRestorative Therapies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • PR2d
    BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform
  • SEC3d
    SEC Form POS AM filed by BioRestorative Therapies Inc.
  • SEC10d
    SEC Form DEF 14A filed by BioRestorative Therapies Inc.
  • SEC20d
    SEC Form PRE 14A filed by BioRestorative Therapies Inc.
  • PR24d
    BioRestorative Therapies Reports Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
  • SEC28d
    SEC Form 10-K filed by BioRestorative Therapies Inc.
  • PR35d
    BioRestorative Therapies to Present Positive Phase 2 Blinded Data for BRTX-100 Demonstrating Meaningful Improvements in Pain and Function in Chronic Lumbar Disc Disease
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022